BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 10373439)

  • 1. Serotonin-2C receptor pre-mRNA editing in rat brain and in vitro by splice site variants of the interferon-inducible double-stranded RNA-specific adenosine deaminase ADAR1.
    Liu Y; Emeson RB; Samuel CE
    J Biol Chem; 1999 Jun; 274(26):18351-8. PubMed ID: 10373439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Editing of glutamate receptor subunit B pre-mRNA by splice-site variants of interferon-inducible double-stranded RNA-specific adenosine deaminase ADAR1.
    Liu Y; Samuel CE
    J Biol Chem; 1999 Feb; 274(8):5070-7. PubMed ID: 9988754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric double-stranded RNA-specific adenosine deaminase ADAR1 proteins reveal functional selectivity of double-stranded RNA-binding domains from ADAR1 and protein kinase PKR.
    Liu Y; Lei M; Samuel CE
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12541-6. PubMed ID: 11070079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccinia virus E3L interferon resistance protein inhibits the interferon-induced adenosine deaminase A-to-I editing activity.
    Liu Y; Wolff KC; Jacobs BL; Samuel CE
    Virology; 2001 Oct; 289(2):378-87. PubMed ID: 11689059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The roles of phospholipase C activation and alternative ADAR1 and ADAR2 pre-mRNA splicing in modulating serotonin 2C-receptor editing in vivo.
    Schmauss C; Zimnisky R; Mehta M; Shapiro LP
    RNA; 2010 Sep; 16(9):1779-85. PubMed ID: 20651031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editing of AMPA and serotonin 2C receptors in individual central neurons, controlling wakefulness.
    Sergeeva OA; Amberger BT; Haas HL
    Cell Mol Neurobiol; 2007 Aug; 27(5):669-80. PubMed ID: 17554622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An RNA editor, adenosine deaminase acting on double-stranded RNA (ADAR1).
    George CX; John L; Samuel CE
    J Interferon Cytokine Res; 2014 Jun; 34(6):437-46. PubMed ID: 24905200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine deaminases acting on RNA, RNA editing, and interferon action.
    George CX; Gan Z; Liu Y; Samuel CE
    J Interferon Cytokine Res; 2011 Jan; 31(1):99-117. PubMed ID: 21182352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of ADAR2-catalyzed editing of the serotonin 2c receptor pre-mRNA by a helix-threading peptide.
    Schirle NT; Goodman RA; Krishnamurthy M; Beal PA
    Org Biomol Chem; 2010 Nov; 8(21):4898-904. PubMed ID: 20820662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functionally distinct double-stranded RNA-binding domains associated with alternative splice site variants of the interferon-inducible double-stranded RNA-specific adenosine deaminase.
    Liu Y; George CX; Patterson JB; Samuel CE
    J Biol Chem; 1997 Feb; 272(7):4419-28. PubMed ID: 9020165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editing of Cellular Self-RNAs by Adenosine Deaminase ADAR1 Suppresses Innate Immune Stress Responses.
    George CX; Ramaswami G; Li JB; Samuel CE
    J Biol Chem; 2016 Mar; 291(12):6158-68. PubMed ID: 26817845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure and sequence determinants required for the RNA editing of ADAR2 substrates.
    Dawson TR; Sansam CL; Emeson RB
    J Biol Chem; 2004 Feb; 279(6):4941-51. PubMed ID: 14660658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of developmental expression of the RNA editing enzyme rADAR2.
    Paupard M-C ; O'Connell MA; Gerber AP; Zukin RS
    Neuroscience; 2000; 95(3):869-79. PubMed ID: 10670454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro analysis of the binding of ADAR2 to the pre-mRNA encoding the GluR-B R/G site.
    Ohman M; Källman AM; Bass BL
    RNA; 2000 May; 6(5):687-97. PubMed ID: 10836790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains.
    Chen CX; Cho DS; Wang Q; Lai F; Carter KC; Nishikura K
    RNA; 2000 May; 6(5):755-67. PubMed ID: 10836796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA editing: rewriting receptors.
    O'Connell MA
    Curr Biol; 1997 Jul; 7(7):R437-9. PubMed ID: 9210370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of binding domains for dsRNA and Z-DNA in the in vivo editing of minimal substrates by ADAR1.
    Herbert A; Rich A
    Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12132-7. PubMed ID: 11593027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADAR2-mediated editing of RNA substrates in the nucleolus is inhibited by C/D small nucleolar RNAs.
    Vitali P; Basyuk E; Le Meur E; Bertrand E; Muscatelli F; Cavaillé J; Huttenhofer A
    J Cell Biol; 2005 Jun; 169(5):745-53. PubMed ID: 15939761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine Deaminases Acting on RNA (ADARs) and Viral Infections.
    Pfaller CK; George CX; Samuel CE
    Annu Rev Virol; 2021 Sep; 8(1):239-264. PubMed ID: 33882257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substrate recognition by ADAR1 and ADAR2.
    Wong SK; Sato S; Lazinski DW
    RNA; 2001 Jun; 7(6):846-58. PubMed ID: 11421361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.